Tigatuzumab (CS-1008)
Revision as of 23:19, 13 June 2018 by Warner-admin (talk | contribs) (Text replacement - "Category:Drug index" to "Category:Drugs")
Mechanism of action
Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2)